Aclaris Therapeutics, Inc. is a clinical stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in dermatology
Quote | Aclaris Therapeutics Inc. (NASDAQ:ACRS)
Last: | $1.39 |
---|---|
Change Percent: | 0.74% |
Open: | $1.34 |
Close: | $1.39 |
High: | $1.41 |
Low: | $1.34 |
Volume: | 402,131 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Aclaris Therapeutics Inc. (NASDAQ:ACRS)
2024-07-16 16:14:56 ET More on Aclaris Therapeutics Aclaris Therapeutics, Inc. (ACRS) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Aclaris Therapeutics Historical earnings data for Aclaris Therapeutics Financial information for Acla...
- Non-Dilutive Transaction Strengthens Balance Sheet to Support Strategic Priorities - - $26.5 Million Upfront Plus Up to $5.0 Million Milestone - WAYNE, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company ...
Message Board Posts | Aclaris Therapeutics Inc. (NASDAQ:ACRS)
Subject | By | Source | When |
---|---|---|---|
I was short premarket 20.30 then quickly covered | alchemytrader | investorshub | 01/20/2021 10:19:02 PM |
ACRS offering more than 5m shares at $17.50/per share | SteevoTrader | investorshub | 01/20/2021 2:01:58 PM |
The way she kept grinding back to 19s | alchemytrader | investorshub | 01/20/2021 4:50:21 AM |
Are we seeing a dump tomorrow? | SteevoTrader | investorshub | 01/20/2021 1:57:36 AM |
Oh really? hit 19.95 today... | alchemytrader | investorshub | 01/20/2021 12:55:29 AM |
News, Short Squeeze, Breakout and More Instantly...
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
Aclaris Therapeutics Inc. Website:
- Non-Dilutive Transaction Strengthens Balance Sheet to Support Strategic Priorities - - $26.5 Million Upfront Plus Up to $5.0 Million Milestone - WAYNE, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company ...
WAYNE, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, Interim President & CEO of Aclaris, will part...
- Progressing ATI-2138 into Atopic Dermatitis - - Management to Host Conference Call at 5:00 PM ET Today - WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidat...